American Pharmacists Associationhttp://www.pharmacist.com/Publications/Pharmacy-Today/December-2022/rss/1296RSS document<![CDATA[Movin’ right along]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/movin-right-alongWed, 21 Dec 2022 20:55:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/movin-right-along<![CDATA[Dancing to the beet]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/dancing-to-the-beetWed, 21 Dec 2022 21:11:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/dancing-to-the-beet<![CDATA[Approval of new ALS drug comes with controversy]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/approval-of-new-als-drug-comes-with-controversyWed, 21 Dec 2022 21:14:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/approval-of-new-als-drug-comes-with-controversy<![CDATA[Eisai to seek FDA approval for lecanemab, one of dozens of drugs in the Alzheimer pipeline]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/eisai-to-seek-fda-approval-for-lecanemab-one-of-dozens-of-drugs-in-the-alzheimer-pipelineWed, 21 Dec 2022 21:18:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/eisai-to-seek-fda-approval-for-lecanemab-one-of-dozens-of-drugs-in-the-alzheimer-pipeline<![CDATA[Ten Humira biosimilars headed to market in 2023]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/ten-humira-biosimilars-headed-to-market-in-2023Wed, 21 Dec 2022 21:23:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/ten-humira-biosimilars-headed-to-market-in-2023<![CDATA[What additional medications might be best for patients taking metformin?]]>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-additional-medications-might-be-best-for-patients-taking-metforminWed, 21 Dec 2022 21:27:00 GMThttp://www.pharmacist.com/Publications/Pharmacy-Today/Article/what-additional-medications-might-be-best-for-patients-taking-metformin